Whitworth, Pat
Beitsch, Peter D.
Pellicane, James V.
Baron, Paul L.
Lee, Laura A.
Dul, Carrie L.
Nash, Charles H. III
Murray, Mary K.
Richards, Paul D.
Gittleman, Mark
Budway, Raye
Layeequr Rahman, Rakhshanda
Kelemen, Pond
Dooley, William C.
Rock, David T.
Cowan, Ken H.
Lesnikoski, Beth-Ann
Barone, Julie L.
Ashikari, Andrew Y.
Dupree, Beth
Wang, Shiyu
Menicucci, Andrea R.
Yoder, Erin B.
Finn, Christine
Corcoran, Kate
Blumencranz, Lisa E.
Audeh, William
,
Article History
First Online: 19 April 2022
Disclosures
: PW, WCD, KHC, CHN, PDR, and BL have contracted research with Agendia Inc. PW serves on the advisory board of Medtronic, Lumicell, ImpediMed, Cianna Medical, Prelude, and Bard Bard; has contracted research with Invitae, Intact, Prelude; has ownership interests in Targeted Medical Education, Reverse Medical, Rebound Medical, Lazarus, Cerebrotech, and Medneon; receives honoraria from Medtronic; and has received travel/accommodations from ImpediMed. JVP receives honoraria as part of Speaker’s Bureau for Agendia Inc. WCD has ownership interests in Shaga Medical, LLC. SW, ARM, EBY, CF, KC, LEB, and WA are non-commercial employees of Agendia Inc. No other disclosures have been reported.